Carbamazepine-Induced Seizures: A Case Report and Review of the Literature

Clinical EEG and Neuroscience

Volumn 33, Issue 4, 2002, Pages 174-177

  Gansaeuer, M ^a   Alsaadi, T M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbamazepine; Induction; Paradoxical Intoxication; Seizures

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; VALPROIC ACID; VERAPAMIL;

ABSENCE; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FEMALE; HEADACHE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SIMPLE PARTIAL SEIZURE; SOMNOLENCE; SPIKE WAVE; SYMPTOM; VISUAL IMPAIRMENT; VOMITING;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; EPILEPSY, ABSENCE; FEMALE; HUMANS;

EID: 0036825164     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005940203300408     Document Type: Article

References (22)

1. Troupin S Ojemann L. Paradoxical intoxication - a complication of anticonvulsant administration. Epilepsia 1975; 16: 753-758.
2. Shields D Saslow E. Myotonic, atonic and absence seizures following institution of carbamazepine therapy in children. Neurology 1983; 33: 1487-1489.
3. Callahan D Noetzel M. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 1992; 42: 2198-2201.
4. Nanba Y Maegaki Y. Epileptic negative myoclonus induced by carbamazepine in a child with BECTS. Pediatric Neurol 1999; 21: 664-667.
5. Johnson S Tarby T. Carbamazepine - induced seizures. Ann Neurol 1984; 16: 392-393.
6. Kimura M Yoshino K Suzuki N. Carbamazepine-exacerbated epilepsy with multifocal shifting independent epileptiform discharges on EEG: a case report. Psychiat Clin Neurosci 1995; 49: 65-67.
7. Horn C Ater S Hurst D. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatric Neurol 1986; 2: 340-345.
8. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia 1986; 27: 706-710.
9. Snead O Hosey L. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985; 313: 916-921.
10. Dhuna A Pascual-Leone A Talwar D. Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine. Epilepsia 1991; 32: 275-278.
11. Parmeggiani A Fraticelli E Rossi P. Exacerbation of epileptic seizures by carbamazepine: report of 10 cases. Seizure 1998; 7: 479-483.
12. Talwar D Arora M Sher P. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994; 35: 1154-1159.
13. Rodin E Rim C Rennick P. The effects of carbamazepine on patients with psychomotor epilepsy: the results of a double-blind study. Epilepsia 1974; 15: 547-561.
14. Wilkus R Dodrill C Troupin A. Carbamazepine and the EEG of epileptics: a double blind study in comparison to phenytoin. Epilepsia 1978; 19 283-291.
15. Geladse T Djibladse M Toidse O Nicolaishvili R. Activation of electroclinical epileptic events by carbamazepine therapy. Epilepsia 1996; 37: (suppl 4) 66.
16. So E Ruggles K Cascino G Ahmann P Weatherford K. Seizure exacerbation and status epilepticus related to carm-bamazepine-10, 11-epoxide. Ann Neurol 1994; 35: 743-746.
17. Sozuer D Atakli D Atay T Baybas S Arpaci B. Evaluation of various antiepileptic drugs in juvenile myoclonic epilepsy. Epilepsia 1996; 37 (suppl 4); 77.
18. Sachdeo R Chokroverty S. Enhancement of absence with tegretol. Epilepsia 1985; 26: 534.
19. Liporace J Sperling M Dichter M. Absence seiures and carbamazepine in adults. Epilepsia 1994; 35: 1026-1028.
20. Genton P Gelisse P Thomas P Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000; 55: 1106-1109.
21. Reutens D Berkovic S. Idiopathic generalized epilepsy of adolescence: Are the syndromes clinically distinct? Neurology 1995; 45: 1469-1476.
22. Neufeld M. Exacerbation of focal seizures due to carbamazepine treatment in an adult patient. Clin Neuropharmacol 1993; 16: 359-361.